Insider sale
RETINALGENIX TECHNOLOGIES INC.
$361.2K
102K shares
What this filing means
BAYERN STEVEN plans to sell 102K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $361.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2025ACC: 0001641172-25-023217
102K
Shares to sell
$361.2K
Approx. market value
4.21M
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
EXERCISE WARRANT
CHECK
9/1/2018
4.21MTotal acquired4.21M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2018 | EXERCISE WARRANT CHECK | 4.21M | — |
| Total | 4.21M | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1K
Market value
$3.5K
7/21/2025
—Completed
Units to sell
1K
Market value
$3.6K
6/2/2025
Planned — Approximate Date
OTCQBPlanned
Units to sell
100K
Market value
$354.0K
8/13/2025
Total
Units
102K
Value
$361.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/21/2025 | 1K | $3.5K | — | Completed |
6/2/2025 | 1K | $3.6K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2025 | 100K | $354.0K | OTCQB | Planned |
| Total | 102K | $361.2K | ||